Document:

Exhibit 10.1

 

MOXIAN
CHINA, INC.

 

Investor
Package

 

This
Investor Package contains the documents listed below in connection with an offering by Moxian China, Inc., a Nevada corporation
(the “Company”), of common stock, par value $.001 per share (“Common Stock”) for gross proceeds
of up to $8,169,000 (or RMB 50,000,000) or such other amount as may be determined by the Company’s board of directors.

 

Subscription
Agreement; Schedules & Exhibits

Disclosure
Schedules

Exhibit
A Common Stock Purchase Warrant

 

Please
deliver your investment amount via wire or check payable to the Company’s account as attached herein as follows:

 

	Bank’s Name:	**********
	Bank Address:	**********
	Account
#: 	**********
	Account
Title:	Moxian Technologies (Shenzhen) Co, Ltd
	 	魔线科技(深圳)有限公司

 

A
signature page package containing segregated signature pages for each of the following documents: (i) the Subscription Agreement
together with the Exhibits and Schedules thereto (collectively, the “Transaction Documents”) has been provided
in a separate Adobe PDF file for your convenience. Please deliver such Transaction Documents to Ofsink, LLC, attention Gracie
Zhou via fax simultaneously with the delivery of the investment amount to the Company.

 

All
copies of executed documents should be sent to the Company’s counsel, Ofsink, LLC, attention Gracie Zhou via fax at (646)
224-9844 or via e-mail at gzhou@golawintl.com.

 

Moxian
China, Inc.

 

    	 

    	 

    

  

Moxian
China, Inc.

 

SUBSCRIPTION
AGREEMENT

 

April
24, 2015

 

Mr. James
Mengdong Tan

CEO

Moxian
China, Inc.

Room
2313-2315 , Block B, Zhongshen Garden

Caitian
South Road, Futian District, Shenzhen

Guangdong
Province, China 518101

 

This
Subscription Agreement (this “Agreement”) is dated as of April 24, 2015 by and between Moxian China, Inc.,
a Nevada corporation, and all predecessors thereof (the “Company”), and
the investor identified on the signature pages hereto (the “Investor”).The undersigned investorhereby irrevocably
subscribes for and agrees to purchase the number of shares (the “Shares”) of the Company’s common stock,
par value $.001 per share (“Common Stock”), set forth on the signature page hereto from Moxian China, Inc.,
a Nevada corporation (the “Company”) for the purchase price of $1.00 per share in connection with the Company’s
offering of $8,169,000 (or approximately RMB 50,000,000) (the “Investment Amount) in Common Stock together with a
warrant for no additional consideration (the “Offering”) in the form of Exhibit A hereto (the “Warrant”),
granting the Investor the right to purchase up to 32,000,000 shares of Common Stock of the Company (“Warrant Shares,”
together with the Shares and Warrant Shares, referred to as the “Securities”). The Warrants will have an initial
exercise price equal to $2.00 per share and shall be exercisable on or prior to July 31, 2015 (the “Expiration Date”).

 

This
Subscription Agreement together with the Exhibits and Schedules thereto constitutes the “Offering Documents.”

 

NOW
THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration
the receipt and adequacy of which are hereby acknowledged, the Company and the Investor hereby agree as follows:

 
DEFINITIONS

 

1.1.Definitions.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms shall have
the meanings indicated in this Section 1.1:

 

“Action”
means any action, suit, inquiry, notice of violation, proceeding (including any partial proceeding such as a deposition) or
investigation pending or threatened in writing against or affecting the Company, any subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency, regulatory or self-regulatory authority (federal, state,
county, local or foreign), stock market, stock exchange or trading facility.

 

    	 

    	 

    

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under
common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Business
Day” means any day except Saturday, Sunday and any day which is a federal legal holiday or a day on which banking institutions
in the State of New York are authorized or required by law or other governmental action to close.

 

“Closing”
means the closing of the purchase and sale of the Securities pursuant to Article 2.

 

“Closing
Date” means the Trading Day on which all of the conditions set forth in Sections 5.1 and 5.2 hereof are satisfied, or
such other date as the parties may agree.

 

“Commission”
means the Securities and Exchange Commission.

 

“Common
Stock” means the common stock of the Company, par value $0.001 per share, and any securities into which such common
stock may hereafter be reclassified or for which it may be exchanged as a class.

 

“Company”
has the meaning set forth in the preamble to this Agreement.

 

“Company
Deliverables” has the meaning set forth in Section 2.2(a).

 

“Disclosure
Materials” has the meaning set forth in Section 3.2(d).

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

“GAAP”
means U.S. generally accepted accounting principles.

 

“Investment
Amount” means shall have the definition set forth in the Recitals above.

 

“Investor
Deliverables” has the meaning set forth in Section 2.2(b).

 

“Lien”
means any lien, charge, encumbrance, security interest, pre-emptive right, right of first refusal, right of participation
or any other restrictions of any kind.

 

“Losses”
means any loss, liability, obligation, claim, contingency, damage, cost or expense, including all judgments, amounts paid
in settlements, court costs and reasonable attorneys’ fees and costs of investigation related thereto.

 

“Material
Adverse Effect” means any of (i) a material and adverse effect on the legality, validity or enforceability of any Transaction
Documents, (ii) a material and adverse effect on the results of operations, assets, properties, prospects, business or condition
(financial or otherwise) of the Company, or (iii) an adverse impairment to the Company’s ability to perform on a timely
basis its obligations under any Transaction Documents; provided however, that none of the following shall be deemed in
and of themselves, either alone or in combination, to constitute, and none of the following shall be taken into account in determining
whether there has been or will be, a Material Adverse Effect: (i) any change, event, state of facts or development generally affecting
the general political, economic or business conditions of the United States; (ii) any change, event, state of facts or development
generally affecting the medical device industry; (iii) any change, event, state of facts or development arising from or relating
to compliance with the terms of this Agreement; (iv) acts of war (whether or not declared), the commencement, continuation or
escalation of a war, acts of armed hostility, sabotage or terrorism or other international or national calamity or any material
worsening of such conditions; (v) changes in laws or GAAP after date hereof or interpretation thereof; or (vi) any matter
set forth in the Transaction Documents or the Schedules or Exhibits thereto.

 

    	2

    	 

    

 

“New
York Courts” means the state and federal courts sitting in the City of New York, Borough of Manhattan.

 

“Per
Share Purchase Price” shall mean $1.00 per share.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited
liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding,
such as a deposition), whether commenced or threatened.

 

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such rule.

 

“Securities
Act” means the Securities Act of 1933, as amended.

 

“Securities”
shall have the meaning as set forth in the recital of this Agreement.

 

“Short
Sales” include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation
SHO under the Exchange Act and all types of direct and indirect stock pledges, forward sale contracts, options, puts, calls, swaps
and similar arrangements (including on a total return basis), and sales and other transactions through non-US broker dealers or
foreign regulated brokers.

 

“Subsidiary”
of any Person means any “significant subsidiary” as defined in Rule 1-02(w) of the Regulation S-X promulgated
by the Commission under the Exchange Act of such Person.

 

“Trading
Day” means a day on which the principal Trading Market is open for trading.

 

“Trading
Market” any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the OTCQB Marketplace of OTC Markets Group Inc., the NYSE MKT, the New York Stock Exchange, the Nasdaq Capital Market,
the Nasdaq Global Market or the Nasdaq Global Select Market (or any successors to any of the foregoing).

 

“Transaction
Documents” means this Agreement, the Warrant and any other documents or agreements executed in connection with the transactions
contemplated hereunder.

 

    	3

    	 

    

  

PURCHASE
AND SALE

  

1.1.Purchase
and Sale; Closing. The closing of the purchase and sale of the Securities for the Investment Amount (the “Closing”)
shall take place as soon as practicable following the satisfaction of the conditions to the Closing set forth herein (or such
later date as is mutually agreed to by the Company and the Investor) (the date of any such Closing is hereinafter referred to
as a “Closing Date”). The Closing shall take place at the offices of the Company at Room 2313-2315, Block B,
Zhongshen Garden, Caitian South Road, Futian District, Shenzhen, Guangdong Province, China 518101 on the Closing Date or at such
other location or time as the parties may agree.

 

1.2.Closing
Deliveries.

 

(a)The
Company shall deliver or cause to be delivered to the Investor the following (the “Company Deliverables”):

 

(i)this
Agreement, duly executed by the Company; and

 

(ii)the
Warrant duly executed by the Company.

 

(b)At
the Closing, Investor shall deliver or cause to be delivered the following to the Company (collectively, the “Investor
Deliverables”):

 

(i)this
Agreement, duly executed by the Investor;

 

(ii)With
the first tranche between RMB20,000,000 to RMB30,000,000 on or before 30th April 2015 and the final remaining
balance to be wired on or before 20th May 2015

 

WIRING
INSTRUCTIONS

 

	Bank’s
    Name:	                                              
	Bank
    Address:	                                              
	Account
    #:	                                              
	Account
    Title:	                                              
	 	                                              

 

    	4

    	 

    

 

REPRESENTATIONS AND WARRANTIES

 

Representations
and Warranties of the Company. Except as set forth in the Disclosure Schedules attached hereto (the “Disclosure Schedules”),
the Company hereby represents and warrants to the Investor the following:

 

(a)Organization
and Standing. The Company is duly incorporated and validly existing under the laws of the State of Nevada, and has all requisite
corporate power and authority to own or lease its properties and assets and to conduct its business as it is presently being conducted.
The Company does not own any equity interest, directly or indirectly, in any other Person or business enterprise. The Company
is in good standing in the State of Nevada and is qualified to do business and is in good standing in each jurisdiction in which
the failure to so qualify could reasonably be expected to have a Material Adverse Effect upon its assets, properties, financial
condition, results of operations or business. Except as provided in Schedule 3.1(a) attached herein, the Company does not
own or control any subsidiaries as of the date of this Agreement.

 

(b)Authorization;
Enforcement. The Company has full corporate power and authority to execute and deliver this Agreement, and any documents and instruments
related to or contemplated by each of the Transaction Documents to which it is or will be a party and to perform its obligations
hereunder and thereunder, and to consummate the transactions contemplated hereby and thereby. The execution and delivery by the
Company of each of the Transaction Documents and the performance by the Company of its obligations thereunder, have been duly
and validly authorized by the Board of Directors, no other corporate action on the part of the Company or its stockholders being
necessary. Each of the Transaction Documents has been or will be duly and validly executed and delivered by the Company, and constitutes,
or will constitute a legal, valid and binding obligation of the Company enforceable against the Company in accordance with their
respective terms except as enforceability may be limited by bankruptcy, insolvency and other laws of general application affecting
the enforcement of creditors’ rights and except that any granting of equitable relief is in the discretion of the court.

 

(c)No
Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company
of the transactions contemplated thereby do not and will not (i) conflict with or violate any provision of the Company’s
certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute
a default (or an event that with notice or lapse of time or both would become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit
facility, debt or other instrument or other understanding to which the Company is a party or by which any property or asset of
the Company is bound or affected, or (iii) result in a violation of any law, rule, regulation, order, judgment, injunction, decree
or other restriction of any court or governmental authority to which the Company is subject (including United States federal and
state securities laws and regulations), or by which any property or asset of the Company is bound or affected; except in the case
of each of clauses (ii) and (iii), such as could not, individually or in the aggregate, have or reasonably be expected to result
in a Material Adverse Effect.

 

    	5

    	 

    

 

(d)Filings,
Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization, approval or order of, give any
notice to, or make any filing or registration with, any federal, provincial, state, local or other governmental authority or any
other Person in connection with the execution, delivery and performance by the Company to the extent a party thereto of the Transaction
Documents, other than (i) filings required by state securities laws, (ii) the filing of a Notice of Sale of Securities on Form
D with the Commission under Regulation D of the Securities Act, (iii) filings, consents and approvals required by the rules and
regulations of the applicable Trading Market and (iv) those that have been made or obtained prior to the date of this Agreement.

 

(e)Issuance
of the Securities. The Securities have been duly authorized and, when issued and paid for in accordance with the Transaction Documents,
will be duly and validly issued, fully paid and non-assessable, free and clear of any and all Liens. Fot the issuance of the Securities,
the Company has reserved from its duly authorized capital stock the number shares of Common Stock representing the Securities
that are issuable pursuant to this Agreement.

 

(f)Capitalization.
The number of shares of all authorized, issued and outstanding capital stock of the Company are specified in Schedule 3.1(f).
No securities of the Company are entitled to preemptive or similar rights, and no Person has any right of first refusal, preemptive
right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.
Except as set forth on Schedule 3.1(f), there are no outstanding options, warrants, scrip rights to subscribe to, calls
or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exchangeable
for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock, or contracts, commitments, understandings
or arrangements by which the Company is or may become bound to issue additional shares of Common Stock, or securities or rights
convertible or exchangeable into shares of Common Stock. The issue and sale of the Securities hereunder will not, immediately
or with the passage of time, obligate the Company to issue shares of Common Stock or other securities to any Person (other than
the Investors) and will not result in a right of any holder of the Company’s securities to adjust the exercise, conversion,
exchange or reset price under such securities.

 

(g)
Litigation. There is no Action which (i) adversely affects or challenges the legality, validity or enforceability of any of the
Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, individually or in the aggregate,
have or reasonably be expected to result in a Material Adverse Effect.

 

The
Investor hereby acknowledges and agrees that the Company does not make and has not made any representations or warranties with
respect to the transactions contemplated hereby other than those specifically set forth in this Section 3.1.

 

    	6

    	 

    

 

Representations
and Warranties of the Investors. The Investor hereby, for itself and for no other Investor, represents and warrants to the Company
as follows:

 

(a)Organization;
Authority. The Investor is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction
of its organization with the requisite corporate or partnership power and authority to enter into and to consummate the transactions
contemplated by the applicable Transaction Documents and otherwise to carry out its obligations thereunder. The execution, delivery
and performance by the Investor of the transactions contemplated by this Agreement has been duly authorized by all necessary corporate
or, if the Investor is not a corporation, such partnership, limited liability company or other applicable like action, on the
part of such Investor. Each of this Agreement and other Transaction Documents has been duly executed by the Investor, and when
delivered by such Investor in accordance with the terms hereof, will constitute the valid and legally binding obligation of such
Investor, enforceable against it in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’
rights and remedies or by other equitable principles of general application.

 

(b)Investment
Intent. Such Investor is acquiring the Securities as principal for its own account for investment purposes only and not with a
view to or for distributing or reselling such Securities or any part thereof, without prejudice, however, to such Investor’s
right at all times to sell or otherwise dispose of all or any part of such Securities in compliance with applicable federal and
state securities laws. Subject to the immediately preceding sentence, nothing contained herein shall be deemed a representation
or warranty by such Investor to hold the Securities for any period of time. Such Investor is acquiring the Securities hereunder
in the ordinary course of its business. Such Investor does not have any agreement or understanding, directly or indirectly, with
any Person to distribute any of the Securities.

 

(c)Investor
Status.

 

(i)The
Investor agrees and acknowledges that it was not, a “U.S. Person” (as defined below) at the time the Investor was
offered the Securities and as of the date hereof:

 

(A)
any natural person resident in the United States;

 

(B)
any partnership or corporation organized or incorporated under the laws of the United States;

 

(C)
any estate of which any executor or administrator is a U.S. person;

 

(D)
any trust of which any trustee is a U.S. person;

 

(E)
any agency or branch of a foreign entity located in the United States;

 

    	7

    	 

    

 

(F)
any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the
benefit or account of a U.S. person;

 

(G)
any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized,
incorporated, or (if an individual) resident of the United States; and

 

(H)
any partnership or corporation if (i) organized or incorporated under the laws of any foreign jurisdiction and (ii) formed
by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is
organized or incorporated, and owned, by accredited Investors (as defined in Rule 501(a) of Regulation D promulgated under the
Securities Act) who are not natural persons, estates or trusts.

 

“United
States” or “U.S.” means the United States of America, its territories and possessions, any State
of the United States, and the District of Columbia.

 

(ii)The
Investor understands that no action has been or will be taken in any jurisdiction by the Company that would permit a public offering
of the Securities in any country or jurisdiction where action for that purpose is required.

 

(iii)The
Investor (i) as of the execution date of this Agreement is not located within the United States, and (ii) is not purchasing the
Securities for the account or benefit of any U.S. Person, except in accordance with one or more available exemptions from the
registration requirements of the Securities Act or in a transaction not subject thereto.

 

(iv)The
Investor will not resell the Securitiess except in accordance with the provisions of Regulation S (Rule 901 through 905 and Preliminary
Notes thereto), pursuant to a registration statement under the Securities Act, or pursuant to an available exemption from registration;
and agrees not to engage in hedging transactions with regard to such securities unless in compliance with the Securities Act.

 

(v)The
Investor will not engage in hedging transactions with regard to shares of the Company prior to the expiration of the distribution
compliance period specified in Category 2 or 3 (paragraph (b)(2) or (b)(3)) in Rule 903 of Regulation S, as applicable, unless
in compliance with the Securities Act; and as applicable, shall include statements to the effect that the securities have not
been registered under the Securities Act and may not be offered or sold in the United States or to U.S. persons (other than distributors)
unless the securities are registered under the Securities Act, or an exemption from the registration requirements of the Securities
Act is available.

 

(vi)No
form of “directed selling efforts” (as defined in Rule 902 of Regulation S under the Securities Act), general solicitation
or general advertising in violation of the Securities Act has been or will be used nor will any offers by means of any directed
selling efforts in the United States be made by the Investor or any of their representatives in connection with the offer and
sale of the Securities.

 

    	8

    	 

    

 

(d)Access
to Information. The Investor acknowledges that it has reviewed the disclosure materials provided by the Company and has been afforded
(i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company
concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities;
(ii) access to information about the Company and its respective financial condition, results of operations, business, properties,
management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional
information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed
investment decision with respect to the investment. Neither such inquiries nor any other investigation conducted by or on behalf
of such Investor or its representatives or counsel shall modify, amend or affect such Investor’s right to rely on the truth,
accuracy and completeness of the Disclosure Materials and the Company’s representations and warranties contained in the
Transaction Documents.

 

(e)The
Investor understands that the offering of the Securities has not been registered under the Securities Act, in reliance on an exemption
for private offerings provided pursuant to Section 4(2) of the Securities Act and that, as a result, the Securities will be “restricted
securities” as that term is defined in Rule 144 under the Securities Act. UNTIL ONE YEAR AFTER THE COMPANY FILES
“Form 10” information with the commission and the other provisins of rule 144 are satisfied, RULE 144 WILL
BE UNAVAILABLE AND THE SECURITIES MAY NOT BE SOLD OTHER THAN IN A PRIVATE TRANSACTION. Once Rule 144 is available, the Securities
must be held for the time period required by Rule 144 (or indefinitely if the Investor is deemed an “affiliate” within
the meaning of such rule) unless the Securities is subsequently registered under the Securities Act and qualified under any other
applicable securities law or exemptions from such registration and qualification are available. The Investor understands that
the Company is under no obligation to register the Securities under the Securities Act or to register or qualify the Securities
under any other applicable securities law, or to comply with any other exemption under the Securities Act or any other securities
law, and that the Investor has no right to require such registration. The Investor understands that the Company has no present
intention to register any of the Securities for re-sale by Investor. The Investor further understands that the Offering of the
Securities has not been qualified or registered under any foreign or state securities laws in reliance upon the representations
made and information furnished by the Investor herein and any other documents delivered by the Investor in connection with this
subscription; that the Offering has not been reviewed by the Commission or by any foreign or state securities authorities; that
the Investor’s rights to transfer the Securities will be restricted, which includes restrictions against transfers unless
the transfer is not in violation of the Securities Act and applicable state securities laws (including investor suitability standards);
and that the Company may in its sole discretion require the Investor to provide at Investor’s own expense an opinion of
its counsel to the effect that any proposed transfer is not in violation of the Securities Act or any state securities laws.

 

    	9

    	 

    

 

(f)Independent
Investment Decision. The Investor has independently evaluated the merits of its decision to purchase the Securities pursuant to
the Transaction Documents, and such Investor confirms that it has not relied on the advice of any other Investor’s business
and/or legal counsel in making such decision. The Investor has not relied on the business or legal advice of the Company or any
of its agents, counsel or Affiliates in making its investment decision hereunder, and confirms that none of such Persons has made
any representations or warranties to such Investor in connection with the transactions contemplated by the Transaction Documents.

 

(g)Trading
Activities. Neither the Investor nor its Affiliates has an open short position in the Company’s Common Stock, and the Investor
agrees that it shall not, and it will cause its Affiliates not to, engage in any Short Sales of or hedging transactions with respect
to the Company’s Common Stock.

 

The
Company acknowledges and agrees that no Investor has made or makes any representations or warranties with respect to the transactions
contemplated hereby other than those specifically set forth in this Section 3.2.

 
OTHER
AGREEMENTS OF THE PARTIES

 

Securities
may only be disposed of in compliance with U.S. state and federal securities laws. In connection with any transfer of the Securities
other than pursuant to an effective registration statement, to the Company, to an Affiliate of an Investor or in connection with
a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion
of counsel selected by the transferor, the form and substance of which opinion shall be reasonably satisfactory to the Company,
to the effect that such transfer does not require registration of such transferred Securities under the Securities Act.

 

(a)Certificates
evidencing the Securities will contain the following legend:

 

THESE
SECURITIES HAVE NOT BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF
ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH
EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. NOTWITHSTANDING THE FOREGOING, THESE SECURITIES
MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES.

 

    	10

    	 

    

 

Integration.
The Company shall not, and shall use its best efforts to ensure that no Affiliate of the Company shall, sell, offer for sale or
solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would
be integrated with the offer or sale of the Securities in a manner that would require the
registration under the Securities Act of the sale of the Securities to the Investors, or that
would be integrated with the offer or sale of the Securities for purposes of the rules and
regulations of any Trading Market in a manner that would require stockholder approval of the sale of the Securities
to the Investors.

 

Use
of Proceeds. The Company will use the net proceeds from the sale of the Securities hereunder for working capital purposes and
such other purposes as set forth on Schedule 4.6 hereto.

 

1.4.Make
Good Provision. If and only if the Investor exercises no less than 16,000,000 of the Warrant and purchases shares of Common Stock
pursuant to such exercise prior to the Expiration Date, the Investor shall be entitled to the following rights:

 

(a)In
the event that the Company does not retain additional 25,000 paying merchants (Paying customers as defined being customers paying
$100 per month) using its online sales platform (the “Make Good Condition”) by September 30, 2016 (“Measurement
Date”), then the Company shall issue and deliver to the Investor, without additional consideration, an additional number
of shares of Common Stock, which is calculated as the following: Warrant Shares issued upon exercise of the Warrant as of the
Measurement Date, multiplied by 50% (the “Make Good Shares”).

 

(b)For
the purpose of determining the satisfaction of Make Good Condition on the Measurement Date, the Company shall produce and provide
to the Investor a list of paying merchants, generated from its online platform no later than 15 days after the Measurement Date
(the “Make Good Notice”). If the Company satisfies the Make Good Condition on the Measurement Date, the Company
shall so state in the Make Good Notice and it shall have no further obligation to issue Make Good Shares to the Investor. If the
Company fails to satisfy the Make Good Condition, the Company shall so state in the Make Good Notice and set forth the number
of Make Good Shares to be issued to the Investor. The Company shall issue and deliver to the Investor the Make Good Shares no
later than thirty (30) days after the Measurement Date.

 

1.5.Board
Representation. As long as the Investor completes the subscription of US$8,169,000 subscription under this Agreement, the Investor
shall have the right to nominate up to one members of the Board of Directors (the “Investor Nominees”). The
Investor may notify the Company of the Investor Nominees to be elected or appointed as directors of the Company immediately after
the Closing and the Board of Directors of the Company shall take such steps as may be necessary to add the Investor Nominees to
the Company’s Board of Directors. As long as the Investor subscribes no less than 16,000,000 warrant on this Agreement,
the Investor will have the right to appoint one nominee to the Board of Directors.

 

    	11

    	 

    

 

1.6.Accounts
Representation. As long as the Investor completes the subscription of US$8,169,000 subscription under this Agreement, the Investor
shall have the right to nominate up to one members to the Company accounts department (the “Account Nominees”).
The Investor may notify the Company of the Account Nominees to be elected or appointed to the Company immediately after the Closing
and the Company shall take such steps as may be necessary to add the Account Nominees to the Company.

 

1.7.Moxian
Version 2.0. The Company hereby covenants and agrees to use its reasonable best efforts to release the Moxian Version 2.0 Beta
App by June 30, 2015 and a full working version of Moxian 2.0 App by September 30, 2015. If the Company fails to deliver Moxian
Version 2.0 by September 30, 2015, the Company shall issue to the Investor 4,000,000 shares at no cost.

 

1.8.Uplisting.
The Company hereby covenants and agrees to use its reasonable best efforts to list its Common Stock on a national stock exchange
in the U.S., including but not limited to, the NYSE MKT, the New York Stock Exchange, the Nasdaq Capital Market, the Nasdaq Global
Market or the Nasdaq Global Select Market (or any successors to any of the foregoing)(‘Exchange’), prior to June 30,
2017. If the Company fails to uplift to an Exchange by June 30, 2017, the Company shall issue to the Investor 4,000,000 shares
at no cost.

 

1.9.Further
Assurances. The Company shall use its reasonable best efforts to satisfy all of the closing conditions under Section 5.1, and
will not take any action which could frustrate or delay the satisfaction of such conditions. In addition, either prior to or following
the Closing, the Company signatory hereto will perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably
request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.

 

CONDITIONS
PRECEDENT TO CLOSING

 

Conditions
Precedent to the Obligations of the Investors to Purchase Securities. The obligation of the Investor to acquire Securities
at the Closing is subject to the satisfaction or waiver by the Investor, at or before the Closing, of each of the following conditions:

 

(a)Representations
and Warranties. The representations and warranties of the Company contained herein shall be true and correct in all material respects
as of the date when made and as of the Closing as though made on and as of such date;

 

(b)Performance.
The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions
required by the Transaction Documents to be performed, satisfied or complied with by it at or prior to the Closing;

 

    	12

    	 

    

 

(c)No
Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents;

 

(d)Adverse
Changes. Since the date of execution of this Agreement, no event or series of events shall have occurred that reasonably could
have or result in a Material Adverse Effect or a material adverse change with respect to the Company; and

 

(e)Company
Deliverables. The Company shall have delivered the Company Deliverables in accordance with Section 2.2(a).

 

Conditions
Precedent to the Obligations of the Company to Sell Securities. The obligation of the Company to sell Securities at the Closing
is subject to the satisfaction or waiver by the Company, at or before the Closing, of each of the following conditions:

 

(a)Representations
and Warranties. The representations and warranties of the Investor contained herein shall be true and correct in all material
respects as of the date when made and as of the Closing Date as though made on and as of such date;

 

(b)Performance.
The Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements and conditions
required by the Transaction Documents to be performed, satisfied or complied with by such Investor at or prior to the Closing;

 

(c)No
Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents; and

 

(d)Investors
Deliverables. The Investor shall have delivered the Investor Deliverables in accordance with Section 2.2(b).
 

MISCELLANEOUS

 

Entire
Agreement. The Transaction Documents, together with the Exhibits and Schedules thereto, contain the entire understanding of the
parties with respect to the subject matter hereof and supersede all prior agreements, understandings, discussions and representations,
oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and
schedules.

 

    	13

    	 

    

 

Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and
shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered
via facsimile (provided the sender receives a machine-generated confirmation of successful transmission) at the facsimile number
specified in this Section prior to 6:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of
transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section on
a day that is not a Trading Day or later than 6:30 p.m. (New York City time) on any Trading Day, or (c) upon actual receipt by
the party to whom such notice is required to be given, if sent by any means other than facsimile transmission. The address for
such notices and communications shall be as follows:

 

	 	If
    to the Company:	Moxian
    China, Inc.
	 	 	Room
    2313-2315, Block B, Zhongshen Garden
	 	 	Caitian
    South Road, Futian District, Shenzhen
	 	 	Guangdong
    Province, China 518101
	 	 	Attn:
    Mr. James Mengdong Tan
	 	 	 
	 	With
    a copy to:	Ofsink,
    LLC
	 	 	230
    Park Ave, Suite 851
	 	 	New
    York, NY 10169
	 	 	Facsimile:
    646-224-9844
	 	 	Attn.:
    Darren Ofsink, Esq.
	 	 	 
	 	If
    to an Investor:	To
    the address set forth under such Investor’s name on the signature pages hereof;

 

or
such other address as may be designated in writing hereafter, in the same manner, by such Person.

 

Amendments;
Waivers; No Additional Consideration. No provision of this Agreement may be waived or amended except in a written instrument signed
by the Company and the Investor. No waiver of any default with respect to any provision, condition or requirement of this Agreement
shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision,
condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner
impair the exercise of any such right. No consideration shall be offered or paid to the Investor to amend or consent to a waiver
or modification of any provision of any Transaction Document unless the same consideration is also offered to all Investors who
then hold Securities.

 

Construction.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party. This Agreement shall be construed
as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue
of the authorship of any provisions of this Agreement or any of the Transaction Documents.

 

    	14

    	 

    

 

Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Investors.
The Investor may assign any or all of its rights under this Agreement to any Person to whom such Investor assigns or transfers
any Securities, provided such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions
hereof that apply to the “Investors.” Notwithstanding anything to the contrary herein, for the avoidance of doubt,
each Investor may freely transfer any Securities to any Person (including its Affiliates or any investment fund sponsored or advised
by such Investor) without the consent of any of the Company or any other Investor.

 

No
Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors and
permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

Governing
Law. This Agreement shall be governed by and construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Agreement shall be governed by, the internal laws of the State of California,
without giving effect to any choice of law or conflict of law provision or rule (whether of the State of California or any other
jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. Each of the
parties hereto hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in New York, New
York for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that
the venue of such suit, action or proceeding is improper. Nothing contained herein shall be deemed to limit in any way any right
to serve process in any manner permitted by law. In the event that any provision of this Agreement is invalid or unenforceable
under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict
therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid
or unenforceable under any law shall not affect the validity or enforceability of any other provision of this Agreement.

 

Survival.
The representations, warranties, agreements and covenants contained herein shall survive the Closing and the delivery of the Securities.

 

Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being
understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission,
such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed)
with the same force and effect as if such facsimile signature page were an original thereof.

 

    	15

    	 

    

 

Severability.
If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the
remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt
to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate
such substitute provision in this Agreement.

 

1.1.Replacement
of Securities. If any certificate or instrument evidencing any Securities is
mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon
cancellation thereof, or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of
evidence reasonably satisfactory to the Company of such loss, theft or destruction and customary and reasonable indemnity, if
requested. The applicants for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs associated with the issuance of such replacement Securities. If a
replacement certificate or instrument evidencing any Securities is requested due to a
mutilation thereof, the Company may require delivery of such mutilated certificate or instrument as a condition precedent to
any issuance of a replacement.
 
 Language and Copies of Agreement. This Agreement shall be executed in English and
Chinese in duplicate, and in case of any conflict the English version shall prevail. Each of the original English and Chinese
versions of this Agreement shall be executed in 2 duplicate copies. Each party shall hold two originals of each
version.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK SIGNATURE PAGES FOLLOW]

 

    	16

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Subscription Agreement to be duly executed by their respective authorized
signatories as of date first written above.

 

	 	Moxian China, Inc.
	 	 	 
	 	By:	 
	 	 	Name:
James Mengdong Tan
	 	 	Title:
Interim Chief Executive Officer

 

    	17

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Subscription Agreement to be duly executed by their respective authorized
signatories as the date set forth above.

 

	 	 	 
	 	INVESTOR
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	Investment
    Amount: $___________
	 	 	 
	 	If
    a U.S. Person, Tax ID or SSN No.:__________
	 	If
    not a U.S. Person, country of incorporation or citizenship:
	 	 	 
	 	ADDRESS
    FOR NOTICE
	 	 
	 	 
	 	 
	 	 	 
	 	Attention:	 
	 	Tel:	 
	 	Email:	
	 	 	 
	 
	MAILING
    ADDRESS
	 	(if
    different from above)
	 	 
	 	 
	 	 
	 	 	 
	 	Attention:	 
	 	Tel:	 
	 	Email:	 

 

    	18

    	 

    

 

DISCLOSURE
SCHEDULES

 

Schedule
3.1(a)

 

Subsidiaries

 

As of the
date of this Agreement herein, the Company has the following subsidiaries:

 

	Name	 	Jurisdiction	 	Equity Owners and Percentage

        of Equity Securities Held

	 	 	 	 	 
	Moxian
    CN Group Limited	 	Samoa	 	100%
    owned by Moxian China, Inc.
	 	 	 	 	 
	Moxian
    Group Limited	 	British
    Virgin Islands	 	100%
    owned by the Moxian CN Group Limited
	 	 	 	 	 
	Moxian
    (Hong Kong) Limited	 	Hong
    Kong	 	100%
    owned by Moxian Group Limited
	 	 	 	 	 
	Moxian
    Technologies (Shenzhen) Co., Ltd.	 	PRC	 	100%
    owned by Moxian (Hong Kong) Limited
	 	 	 	 	 
	Moxian
    Malaysia SDN BHD	 	Malaysia	 	100%
    owned by Moxian (Hong Kong) Limited

  

    	19

    	 

    

 

Schedule
3.1(f)

 

Capitalization

 

As of the
date of this Agreement, the Company is authorized to issue a total of 500,000,000 shares of Common Stock, with 198,300,000 shares
issued and outstanding and the Company is authorized to issue 100,000,000 shares of preferred stock, par value $0.001 per share
with no share issued or outstanding.

 

There are
no warrants or options or any obligation to issue the Company’s securities issued and outstanding as of the date of this
Agreement.

 

    	20

    	 

    

 

Schedule
4.6

 

Use
of Proceeds

 

We intend
to use the estimated net proceeds of the Offering for working capital.

 

    	21

    	 

    

EXHIBIT A

 

For
U.S. Investors

 

these
securities have not been registered with the united states securities and exchange commission or the securities commission of
any state pursuant to an exemption from registration under regulation d promulgated under the securities act of 1933, as amended
(the “act”). this warrant shall not constitute an offer to sell nor a solicitation of an offer to buy the securities
in any jurisdiction in which such offer or solicitation would be unlawful. the securities are “restricted” and
may not be resold or transferred except as permitted under the act pursuant to registration or exemption therefrom.

 

For
Non-U.S. Investors:

 

THESE
SECURITIES WERE ISSUED IN AN OFFSHORE TRANSACTION TO PERSONS WHO ARE NOT U.S. PERSONS (AS DEFINED IN REGULATION S) PURSUANT TO
REGULATION S PROMULGATED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). ACCORDINGLY,
NONE OF THE SECURITIES REPRESENTED HEREBY HAVE BEEN REGISTERED UNDER THE SECURITIES ACT, OR ANY U.S. STATE SECURITIES LAWS, AND,
UNLESS SO REGISTERED, NONE MAY BE OFFERED OR SOLD IN THE UNITED STATES OR, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT OR PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT, AND IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING
TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN ACCORDANCE WITH THE SECURITIES ACT.

 

COMMON
STOCK PURCHASE WARRANT

 

To
Purchase Shares of $0.001 Par Value Common Stock (“Common Stock”) of No. [W-__]

 

MOXIAN
CHINA, INC.

 

THIS
CERTIFIES that, for value received, INVESTOR (the “Purchaser” or “Holder”) is entitled,
upon the terms and subject to the conditions hereinafter set forth, at any time on or after the date hereof and on or prior to
8:00 p.m. New York City Time on July 31, 2015 (the “Termination Date”), but not thereafter, to subscribe for
and purchase from Moxian China, Inc., a Nevada corporation (the “Company”) up to 32,000,000 shares of the Company’s
common stock (“Warrant Shares”) at an initial exercise price of $2.00 per share (as adjusted from time to time
pursuant to the terms hereof, the “Exercise Price”).

 

The
Exercise Price and the number of shares for which the Warrant is exercisable shall be subject to adjustment as provided herein.
This Warrant is being issued in connection with the Subscription Agreement dated _________ (the “Subscription Agreement”),
entered into between the Company and accredited investors in connection with the Company’s offering by the Company of its
Common Stock (the “Common Stock,” and such offering, the “Offering”).

 

    	22

    	 

    

 

Capitalized
terms used herein and not otherwise defined shall have the meaning ascribed to them in the Subscription Agreement.

 

		1.	Title
                                         of Warrant. Prior to the expiration hereof and subject to compliance with applicable
                                         laws, this Warrant and all rights hereunder are transferable, in whole or in part, at
                                         the office or agency of the Company by the Holder hereof in person or by duly authorized
                                         attorney, upon surrender of this Warrant together with (a) the Assignment Form
                                         annexed hereto properly endorsed, and (b) any other documentation reasonably necessary
                                         to satisfy the Company that such transfer is in compliance with all applicable securities
                                         laws. The term “Holder” shall refer to the Purchaser or any subsequent
                                         transferee of this Warrant.

 

		2.	Authorization
                                         of Shares. The Company covenants that all shares of Common Stock which may be
                                         issued upon the exercise of rights represented by this Warrant will, upon exercise of
                                         the rights represented by this Warrant and payment of the Exercise Price as set forth
                                         herein, be duly authorized, validly issued, fully paid and non-assessable and free from
                                         all taxes, liens and charges in respect of the issue thereof (other than taxes in respect
                                         of any transfer occurring contemporaneously with such issue or otherwise specified herein).

 

		3.	Exercise
                                         of Warrant.

 

		a.	The
                                         Holder may exercise this Warrant, in whole or in part, at any time and from time to time
                                         by delivering (which may be by facsimile) to the offices of the Company or any transfer
                                         agent for the Common Stock this Warrant, together with a Notice of Exercise in
                                         the form annexed hereto specifying the number of Warrant Shares with respect to which
                                         this Warrant is being exercised, together with payment in cash to the Company of the
                                         Exercise Price therefore.

 

		b.	In
                                         the event that the Warrant is not exercised in full, the number of Warrant Shares shall
                                         be reduced by the number of such Warrant Shares for which this Warrant is exercised and/or
                                         surrendered, and the Company, if requested by Holder and at its expense, shall within
                                         five (5) Trading Days (as defined below) issue and deliver to the Holder a new Warrant
                                         of like tenor in the name of the Holder or as the Holder (upon payment by Holder of any
                                         applicable transfer taxes) may request, reflecting such adjusted Warrant Shares. Notwithstanding
                                         anything to the contrary set forth herein, upon exercise of any portion of this Warrant
                                         in accordance with the terms hereof, the Holder shall not be required to physically surrender
                                         this Warrant to the Company unless such Holder is purchasing the full amount of Warrant
                                         Shares represented by this Warrant. The Holder and the Company shall maintain records
                                         showing the number of Warrant Shares so purchased hereunder and the dates of such purchases
                                         or shall use such other method, reasonably satisfactory to the Holder and the Company,
                                         so as not to require physical surrender of this Warrant upon each such exercise. The
                                         Holder and any assignee, by acceptance of this Warrant or a new Warrant, acknowledge
                                         and agree that, by reason of the provisions of this Section, following exercise of any
                                         portion of this Warrant, the number of Warrant Shares which may be purchased upon exercise
                                         of this Warrant may be less than the number of Warrant Shares set forth on the face hereof.
                                         Certificates for shares of Common Stock purchased hereunder shall be delivered to the
                                         Holder hereof within ten (10) Trading Days after the date on which this Warrant shall
                                         have been exercised as aforesaid. The Holder may withdraw its Notice of Exercise at any
                                         time if the Company fails to timely deliver the relevant certificates to the Holder as
                                         provided in this Agreement. A Notice of Exercise shall be deemed sent on the date of
                                         delivery if delivered before 8:00 p.m. New York Time on such date, or the day following
                                         such date if delivered after 8:00 p.m. New York Time; provided that the Company is only
                                         obligated to deliver Warrant Shares against delivery of the Exercise Price from the holder
                                         hereof and, if the Holder is purchasing the full amount of Warrant Shares represented
                                         by this Warrant, surrender of this Warrant (or appropriate affidavit and/or indemnity
                                         in lieu thereof).

 

    	23

    	 

    

 

The
Company’s obligations to issue and deliver Warrant Shares upon an exercise in accordance with Section 3 above are absolute
and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect
to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim,
recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to
the Company or any violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance
which might otherwise limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Nothing
herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including,
without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely
deliver certificates representing shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

 

		4.	No
                                         Fractional Shares or Scrip. No fractional shares or scrip representing fractional
                                         shares shall be issued upon the exercise of this Warrant. In lieu of issuance of a fractional
                                         share upon any exercise hereunder, the Company will either round up to nearest whole
                                         number of shares or pay the cash value of that fractional share, which cash value shall
                                         be calculated on the basis of the average closing price of the Common Stock during the
                                         five (5) Trading Days immediately preceding the date of exercise.

 

		5.	Charges,
                                         Taxes and Expenses. Issuance of certificates for shares of Common Stock upon
                                         the exercise of this Warrant shall be made without charge to the Holder hereof for any
                                         issue or transfer tax or other incidental expense in respect of the issuance of such
                                         certificate, all of which taxes and expenses shall be paid by the Company, and such certificates
                                         shall be issued in the name of the Holder of this Warrant or in such name or names as
                                         may be directed by the Holder of this Warrant; provided, however, that in the event certificates
                                         for shares of Common Stock are to be issued in a name other than the name of the Holder
                                         of this Warrant, this Warrant when surrendered for exercise shall be accompanied by the
                                         Assignment Form attached hereto duly executed by the Holder hereof; and provided further,
                                         that the Company shall not be required to pay any tax or taxes which may be payable in
                                         respect of any transfer involved in the issuance of any Warrant certificates or any certificates
                                         for the Warrant Shares other than the issuance of a Warrant Certificate to the Holder
                                         in connection with the Holder’s surrender of a Warrant Certificate upon the exercise
                                         of all or less than all of the Warrants evidenced thereby.

 

    	24

    	 

    

 

		6.	Closing
                                         of Books. The Company will at no time close its shareholder books or records
                                         in any manner which interferes with the timely exercise of this Warrant.

 

		7.	No
                                         Rights as Shareholder until Exercise. Subject to Section 13 of this Warrant and
                                         the provisions of any other written agreement between the Company and the Purchaser,
                                         the Purchaser shall not be entitled to vote or receive dividends or be deemed the holder
                                         of Warrant Shares or any other securities of the Company that may at any time be issuable
                                         on the exercise hereof for any purpose, nor shall anything contained herein be construed
                                         to confer upon the Purchaser, as such, any of the rights of a stockholder of the Company
                                         or any right to vote for the election of directors or upon any matter submitted to stockholders
                                         at any meeting thereof, or to give or withhold consent to any corporate action (whether
                                         upon any recapitalization, issuance of stock, reclassification of stock, change of par
                                         value, or change of stock to no par value, consolidation, merger, conveyance or otherwise)
                                         or to receive notice of meetings, or to receive dividends or subscription rights or otherwise
                                         until the Warrant shall have been exercised as provided herein. However, at the time
                                         of the exercise of this Warrant pursuant to Section 3 hereof, the Warrant Shares so purchased
                                         hereunder shall be deemed to be issued to such Holder as the record owner of such shares
                                         as of the close of business on the date on which this Warrant shall have been exercised.

 

		8.	Assignment
                                         and Transfer of Warrant. This Warrant may not be assigned or transfer without
                                         the written consent with the Company.

 

		9.	Loss,
                                         Theft, Destruction or Mutilation of Warrant; Exchange. The Company represents,
                                         warrants and covenants that (a) upon receipt by the Company of evidence and/or indemnity
                                         reasonably satisfactory to it of the loss, theft, destruction or mutilation of any Warrant
                                         or stock certificate representing the Warrant Shares, and in case of loss, theft or destruction,
                                         of indemnity reasonably satisfactory to it, and (b) upon surrender and cancellation of
                                         such Warrant or stock certificate, if mutilated, the Company will make and deliver a
                                         new Warrant or stock certificate of like tenor and dated as of such cancellation, in
                                         lieu of this Warrant or stock certificate, without any charge therefor. This Warrant
                                         is exchangeable at any time for an equal aggregate number of Warrants of different denominations,
                                         as requested by the holder surrendering the same, or in such denominations as may be
                                         requested by the Holder following determination of the Exercise Price. No service charge
                                         will be made for such registration or transfer, exchange or reissuance.

 

		10.	Saturdays,
                                         Sundays, Holidays, etc. If the last or appointed day for the taking of any action
                                         or the expiration of any right required or granted herein shall be a Saturday, Sunday
                                         or a legal holiday, then such action may be taken or such right may be exercised on the
                                         next succeeding day not a legal holiday.

 

		11.	Effect
                                         of Certain Events. If at any time while this Warrant or any portion thereof is
                                         outstanding and unexpired there shall be a transaction (by merger or otherwise) in which
                                         more than 50% of the voting power of the Company is disposed of (collectively, a “Sale
                                         or Merger Transaction”), the Holder of this Warrant shall have the right thereafter
                                         to purchase, by exercise of this Warrant and payment of the aggregate Exercise Price
                                         in effect immediately prior to such action, the kind and amount of shares and other securities
                                         and property which it would have owned or have been entitled to receive after the happening
                                         of such transaction had this Warrant been exercised immediately prior thereto, subject
                                         to further adjustment as provided in Section 12.

 

    	25

    	 

    

 

		12.	Adjustments
                                         of Exercise Price and Number of Warrant Shares. The number of and kind of securities
                                         purchasable upon exercise of this Warrant and the Exercise Price shall be subject to
                                         adjustment from time to time as set forth in this Section 12.

 

		a.	Subdivisions,
                                         Combinations, Stock Dividends and other Issuances. If the Company shall, at any
                                         time while this Warrant is outstanding, (i) pay a stock dividend or otherwise make a
                                         distribution or distributions on any equity securities (including instruments or securities
                                         convertible into or exchangeable for such equity securities) in shares of Common Stock,
                                         (ii) subdivide outstanding shares of Common Stock into a larger number of shares, or
                                         (iii) combine outstanding Common Stock into a smaller number of shares, then the Exercise
                                         Price shall be multiplied by a fraction, the numerator of which shall be the number of
                                         shares of Common Stock outstanding before such event and the denominator of which shall
                                         be the number of shares of Common Stock outstanding after such event. Any adjustment
                                         made pursuant to this Section 12(a) shall become effective immediately after the record
                                         date for the determination of stockholders entitled to receive such dividend or distribution
                                         and shall become effective immediately after the effective date in the case of a subdivision
                                         or combination. The number of shares which may be purchased hereunder shall be increased
                                         proportionately to any reduction in Exercise Price, or decreased proportionately to any
                                         increase in Exercise Price, pursuant to this paragraph 12(a), so that after such adjustments
                                         the aggregate Exercise Price payable hereunder for the applicable number of shares shall
                                         be the same as the aggregate Exercise Price in effect just prior to such adjustments.

 

		b.	Other
                                         Distributions. If at any time after the date hereof the Company distributes to
                                         holders of its Common Stock, other than as part of its dissolution, liquidation or the
                                         winding up of its affairs, any shares of its capital stock, any evidence of indebtedness
                                         or any of its assets (other than Common Stock), then the number of Warrant Shares for
                                         which this Warrant is exercisable shall be increased to equal: (i) the number of Warrant
                                         Shares for which this Warrant is exercisable immediately prior to such event, (ii) multiplied
                                         by a fraction, (A) the numerator of which shall be the Fair Market Value (as defined
                                         below) per share of Common Stock on the record date for the dividend or distribution,
                                         and (B) the denominator of which shall be the Fair Market Value price per share of Common
                                         Stock on the record date for the dividend or distribution minus the amount allocable
                                         to one share of Common Stock of the value (as jointly determined in good faith by the
                                         Board of Directors of the Company and the Holder) of any and all such evidences of indebtedness,
                                         shares of capital stock, other securities or property, so distributed. For purposes of
                                         this Warrant, “Fair Market Value” shall equal the average closing
                                         trading price of the Common Stock on the Principal Market for the five (5) Trading Days
                                         preceding the date of determination or, if the Common Stock is not listed or admitted
                                         to trading on any Principal Market, and the average price cannot be determined as contemplated
                                         above, the Fair Market Value of the Common Stock shall be as reasonably determined in
                                         good faith by the Company’s Board of Directors and the Holder. If the Fair Market
                                         Value of the Common Stock cannot be determined by the Company’s Board of Directors
                                         and the Holder after five (5) business days, such determination shall be made by a third
                                         party appraisal firm mutually agreeable by the Board of Directors and the Holder, at
                                         the expense of the Company (the “Independent Appraiser”). The fair
                                         market value as determined by the Independent Appraiser shall be final. The Exercise
                                         Price shall be reduced to equal: (i) the Exercise Price in effect immediately before
                                         the occurrence of any event (ii) multiplied by a fraction, (A) the numerator of which
                                         is the number of Warrant Shares for which this Warrant is exercisable immediately before
                                         the adjustment, and (B) the denominator of which is the number of Warrant Shares for
                                         which this Warrant is exercisable immediately after the adjustment.

 

    	26

    	 

    

 

		c.	Merger,
                                         etc. If at any time after the date hereof there shall be a merger or consolidation
                                         of the Company with or into or a transfer of all or substantially all of the assets of
                                         the Company to another entity, then the Holder shall be entitled to receive upon or after
                                         such transfer, merger or consolidation becoming effective, and upon payment of the Exercise
                                         Price then in effect, the number of shares or other securities or property of the Company
                                         or of the successor corporation resulting from such merger or consolidation, which would
                                         have been received by the Holder for the shares of stock subject to this Warrant had
                                         this Warrant been exercised just prior to such transfer, merger or consolidation becoming
                                         effective or to the applicable record date thereof, as the case may be. The Company will
                                         not merge or consolidate with or into any other corporation, or sell or otherwise transfer
                                         its property, assets and business substantially as an entirety to another corporation,
                                         unless the corporation resulting from such merger or consolidation (if not the Company),
                                         or such transferee corporation, as the case may be, shall expressly assume in writing
                                         the due and punctual performance and observance of each and every covenant and condition
                                         of this Warrant to be performed and observed by the Company.

 

		d.	Reclassification,
                                         etc. If at any time after the date hereof there shall be a reorganization or
                                         reclassification of the securities as to which purchase rights under this Warrant exist
                                         into the same or a different number of securities of any other class or classes, then
                                         the Holder shall thereafter be entitled to receive upon exercise of this Warrant, during
                                         the period specified herein and upon payment of the Exercise Price then in effect, the
                                         number of shares or other securities or property resulting from such reorganization or
                                         reclassification, which would have been received by the Holder for the shares of stock
                                         subject to this Warrant had this Warrant at such time been exercised.

 

		13.	Notice
                                         of Adjustment. Whenever the number of Warrant Shares or number or kind of securities
                                         or other property purchasable upon the exercise of this Warrant or the Exercise Price
                                         is adjusted, the Company, at its expense, shall promptly mail to the Holder of this Warrant
                                         a notice setting forth the number of Warrant Shares (and other securities or property)
                                         purchasable upon the exercise of this Warrant and the Exercise Price of such Warrant
                                         Shares after such adjustment and setting forth the computation of such adjustment and
                                         a brief statement of the facts requiring such adjustment.

 

    	27

    	 

    

 

		14.	Authorized
                                         Shares. The Company covenants that during the period the Warrant is outstanding
                                         and exercisable, it will reserve and keep available from its authorized and unissued
                                         Common Stock a sufficient number of shares to provide solely for the issuance of the
                                         Warrant Shares upon the exercise of any and all purchase rights under this Warrant. The
                                         Company further covenants that its issuance of this Warrant shall constitute full authority
                                         to its officers who are charged with the duty of executing stock certificates to execute
                                         and issue the necessary certificates for the Warrant Shares upon the exercise of the
                                         purchase rights under this Warrant. The Company will take all such reasonable action
                                         as may be necessary to assure that such Warrant Shares may be issued as provided herein
                                         without violation of any applicable law, regulation, or rule of any applicable market
                                         or exchange.

 

		15.	Compliance
                                         with Securities Laws. The Holder hereof acknowledges that the Warrant Shares
                                         acquired upon the exercise of this Warrant, if not registered (or if no exemption from
                                         registration exists), will have restrictions upon resale imposed by state and federal
                                         securities laws. Each certificate representing the Warrant Shares issued to the Holder
                                         upon exercise (if not registered, for resale or otherwise, or if no exemption from registration
                                         exists) will bear substantially the following legend: THE SHARES REPRESENTED BY THIS
                                         CERTIFICATE HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
                                         SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
                                         THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND,
                                         ACCORDINGLY, MAY NOT BE OFFERED, TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT PURSUANT
                                         TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
                                         EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF
                                         THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

 

		16.	Purpose
                                         of Warrant Shares. Without limiting the Purchaser’s right to transfer,
                                         assign or otherwise convey the Warrant or Warrant Shares in compliance with all applicable
                                         securities laws, the Holder of this Warrant, by acceptance hereof, acknowledges that
                                         this Warrant and the Warrant Shares to be issued upon exercise hereof are being acquired
                                         solely for the Purchaser’s own account and not as a nominee for any other party,
                                         and that the Purchaser will not offer, sell or otherwise dispose of this Warrant or any
                                         Warrant Shares to be issued upon exercise hereof except under circumstances that will
                                         not result in a violation of applicable federal and state securities laws.

 

		17.	Miscellaneous.

 

		a.	Issue
                                         Date; Choice of Law; Venue; Jurisdiction. The provisions of this Warrant shall
                                         be construed and shall be given effect in all respects as if it had been issued and delivered
                                         by the Company on the date hereof. This Warrant shall be binding upon any successors
                                         or assigns of the Company. This Warrant will be construed and enforced in accordance
                                         with and governed by the laws of the State of New York, except for matters arising under
                                         the Act, without reference to principles of conflicts of law. Each of the parties consents
                                         to the exclusive jurisdiction of the Federal and State Courts sitting in the County of
                                         New York in the State of New York in connection with any dispute arising under this Warrant
                                         and hereby waives, to the maximum extent permitted by law, any objection, including any
                                         objection based on forumnonconveniens or venue, to the bringing of any such proceeding
                                         in such jurisdiction.

 

    	28

    	 

    

 

		b.	Modification
                                         and Waiver. This Warrant and any provisions hereof may be changed, waived, discharged
                                         or terminated only by an instrument in writing signed by the party against which enforcement
                                         of the same is sought. Any amendment effected in accordance with this paragraph shall
                                         be binding upon the Purchaser, each future holder of this Warrant and the Company. No
                                         waivers of, or exceptions to, any term, condition or provision of this Warrant, in any
                                         one or more instances, shall be deemed to be, or construed as, a further or continuing
                                         waiver of any such term, condition or provision.
	 	 	 
		c.	Notices.
                                         Any notice or other communication required or permitted to be given hereunder shall
                                         be in writing by facsimile, mail or personal delivery and shall be effective upon actual
                                         receipt of such notice. The addresses for such communications shall be to the addresses
                                         as shown on the books of the Company or to the Company at the address set forth for Moxian
                                         China, Inc. in the Offering Documents. A party may from time to time change the address
                                         to which notices to it are to be delivered or mailed hereunder by notice in accordance
                                         with the provisions of this Section 19(c).
	 	 	 
		d.	Severability.
                                         Whenever possible, each provision of this Warrant shall be interpreted in such manner
                                         as to be effective and valid under applicable law, but if any provision of this Warrant
                                         is held to be invalid, illegal or unenforceable in any respect under any applicable law
                                         or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not
                                         affect the validity, legality or enforceability of any other provision of this Warrant
                                         in such jurisdiction or affect the validity, legality or enforceability of any provision
                                         in any other jurisdiction, but this Warrant shall be reformed, construed and enforced
                                         in such jurisdiction as if such invalid, illegal or unenforceable provision had never
                                         been contained herein.

 

		e.	Specific
                                         Enforcement. The Company and the Holder acknowledge and agree that irreparable
                                         damage would occur in the event that any of the provisions of this Warrant were not performed
                                         in accordance with their specific terms or were otherwise breached. It is accordingly
                                         agreed that the parties shall be entitled to an injunction or injunctions to prevent
                                         or cure breaches of the provisions of this Warrant and to enforce specifically the terms
                                         and provisions hereof, this being in addition to any other remedy to which either of
                                         them may be entitled by law or equity.

 

    	29

    	 

    

 

		f.	Counterparts/Execution.
                                         This Warrant may be executed by facsimile and in any number of counterparts, and
                                         each such counterpart hereof shall be deemed to be an original instrument, but all such
                                         counterparts together shall constitute one agreement. Execution and delivery of this
                                         Warrant by facsimile transmission (including delivery of documents in Adobe PDF format)
                                         shall constitute execution and delivery of this Warrant for all purposes, with the same
                                         force and effect as execution and delivery of an original manually signed copy hereof.

 

[SIGNATURE
PAGE TO FOLLOW]

 

    	30

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officers thereunto duly authorized.

 

Dated:
May 15, 2015

 

	MOXIAN
    CHINA, INC.	 
	 	 
	By:	 	 
	Name:  	James
    Mengdong Tan	 
	Title:	Interim
    Chief Executive Officer	 

    	31

    	 

    

 

NOTICE
OF EXERCISE

 

To: MOXIAN
CHINA, INC.

 

(1)The
undersigned hereby elects to exercise the attached Warrant for and to purchase thereunder, ________________ shares of Common Stock,
and herewith makes payment therefor of $______________.

 

(2)Please
issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned or in such other name
as is specified below:

 

	 	 	 
	 	(Name)	 
	 	 	 
	 	(Address)	 
	 	 	 

 

(3)Please
issue a new Warrant for the unexercised portion of the attached Warrant in the name of the undersignedas is specified below:

 

	 	 	INVESTOR
	 	 	 
	 	 	(Name)
	 	 	 
	(Date)	 	(Signature)
	 	 	 
	 	 	(Address)
	Dated:	 	 
	 	 	 
	 	 	 
	SignatureExhibit 4.1

 

NEITHER THESE SECURITIES NOR THE SECURITIES
FOR WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES
ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THESE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE
SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN FROM AN ACCREDITED INVESTOR SECURED BY SUCH
SECURITIES.

 

INVENTERGY GLOBAL, INC.

 

WARRANT

 

	Warrant No. 1	Dated:  February 25, 2015

 

Inventergy Global, Inc.,
a Delaware corporation (the “Company”), hereby certifies that, for value received, CF DB EZ LLC or its
registered assigns (including permitted transferees, the “Holder”), as registered owner of this warrant
(the “Warrant”), is entitled to purchase from the Company up to a total of 500,000 shares (as
adjusted from time to time as provided in Section 9) of Common Stock (as defined below), at an exercise price a price
per share equal to $1.14 (as adjusted from time to time as provided in Section 9, the “Exercise
Price”), at any time and from time to time from and after the date hereof (the “Initial Exercise Date”)
to and including the seven year anniversary of the date hereof (the “Expiration Date”), and subject to
the following terms and conditions.

 

1.
Definitions. The capitalized terms used herein and not otherwise defined shall have the meanings set forth below:

 

“Affiliate”
of any specified Person means any other person or entity directly or indirectly controlling, controlled by or under direct or indirect
common control with such specified Person. For purposes of this definition, “control” means the power
to direct the management and policies of such Person or firm, directly or indirectly, whether through the ownership of voting securities,
by contract or otherwise.

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Common Stock”
means the common stock of the Company, $0.0001 par value per share.

 

“Eligible Market”
means any of the New York Stock Exchange, the NYSE Amex or Nasdaq (as defined below), and any successor markets thereto.

 

“Exchange Act”
means the Securities Exchange Act of 1934, as amended

 

    	 

    	 

    

  

“Market Price”
shall mean (i) if the principal trading market for such securities is an exchange, the average of the last reported sale prices
per share for the last ten previous Trading Days in which a sale was reported, as officially reported on any consolidated tape,
(ii) if clause (i) is not applicable, the average of the closing bid price per share for the last ten previous Trading
Days as quoted by OTC Markets, Inc. for such securities. Notwithstanding the foregoing, if there is no reported sales price or
closing bid price, as the case may be, on any of the ten Trading Days preceding the event requiring a determination of Market Price
hereunder, then the Market Price shall be determined in good faith after reasonable investigation by resolution of the Board of
Directors of the Company.

 

“Nasdaq”
means the Nasdaq Global Market or Nasdaq Capital Market, and any successor markets thereto.

 

“Other Securities”
refers to any capital stock (other than Common Stock) and other securities of the Company or any other Person which the Holder
of this Warrant at any time shall be entitled to receive, or shall have received, pursuant to the terms hereof upon the exercise
of this Warrant, in lieu of or in addition to Common Stock.

 

“Person”
means any court or other federal, state, local or other governmental authority or other individual or corporation, partnership,
trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or
an agency or subdivision thereof) or other entity of any kind.

 

“Trading Day”
means (a) any day on which the Common Stock is listed or quoted and traded on any Eligible Market or (b) if the Common
Stock is not then quoted and traded on any Eligible Market, then a day on which trading occurs on the OTCQB or OTCQX markets maintained
by OTC Markets, Inc.(or any successor thereto).

 

“Warrant Shares”
shall initially mean shares of Common Stock and in addition may include Other Securities and Substituted Property (as defined in
Section 9(e)(x)) issued or issuable from time to time upon exercise of this Warrant.

 

2.
Registration of Warrant. The Company shall register this Warrant, upon records to be maintained by the Company for
that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The
Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof
or any distribution to the Holder, and for all other purposes.

 

3.
Registration of Transfers. The Company shall register the transfer of any portion of this Warrant in the Warrant
Register, upon surrender of this Warrant, with the Form of Assignment attached hereto as Appendix A duly completed
and signed, to the Company at its address specified herein. Upon any such registration and transfer, a new warrant in substantially
the form of a Warrant (any such new warrant, a “New Warrant”), evidencing the portion of this Warrant
so transferred shall be issued to the transferee and a New Warrant evidencing the remaining portion of this Warrant not so transferred,
if any, shall be issued to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed
the acceptance by such transferee of all of the rights and obligations of a holder of a Warrant.

 

4.
Exercise and Duration of Warrant.

 

(a)
This Warrant shall be exercisable, either in its entirety or for a portion of the number of Warrant Shares, by the registered
Holder at any time and from time to time from and after the initial Exercise Date (as defined below) to and including the Expiration
Date. At 5:00 P.M. New York City time on the Expiration Date, the portion of this Warrant not exercised prior thereto shall
be and become void and of no value, and the Holder hereof shall have no right to purchase any additional Warrant Shares hereunder.

 

    	-2-

    	 

    

 

(b)
A Holder may exercise this Warrant by delivering to the Company, in accordance with Section 13, this Warrant, together
with (i) an exercise notice, in the form attached hereto as Appendix B (the “Exercise Notice”),
appropriately completed and duly signed, and (ii) (A) payment of the Exercise Price for the number of Warrant Shares as to which
this Warrant is being exercised pursuant to a Cash Exercise (as set forth in Section 4(c) below) or (B) if available
pursuant to Section 4(d) below, by notifying the Company that this Warrant is being exercised pursuant to a Cashless Exercise
(as set forth in Section 4(d) below), and the date such items are received by the Company is an “Exercise Date.”
Execution and delivery of an Exercise Notice in respect of less than all of the Warrant Shares issuable upon exercise of this Warrant
shall result in the cancellation of the original Warrant and issuance of a New Warrant evidencing the right to purchase the remaining
number of Warrant Shares. For clarity, the Holder may exercise any or all for the remaining portion of this Warrant notwithstanding
that the Company has not returned a physical New Warrant certificate to the Holder, by delivering a further Exercise Notice and
tendering payment of the Exercise Price (or Cashless Exercise notice) as aforesaid.

 

(c)
Cash Exercise. In the event the Holder has elected to pay the Exercise Price in cash, it shall pay the Exercise Price
by certified bank check payable to the order of the Company or by wire transfer of immediately available funds in accordance with
the Company’s instructions (a “Cash Exercise”).

 

(d)
Cashless Exercise. Notwithstanding anything contained herein to the contrary, if, at any time a registration statement
covering the resale of the Warrant Shares that are the subject of the Exercise Notice by the Holder pursuant to the Securities
Act (the “Unavailable Warrant Shares”) is not available for the resale of such Unavailable Warrant Shares,
and the Company is otherwise obligated to have a resale registration statement available for such resale, the Holder may, in its
sole discretion, exercise this Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be
made to the Company upon such exercise in payment of the Exercise Price, elect instead to receive upon such exercise the “Net
Number” of shares of Common Stock determined according to the following formula (a “Cashless Exercise”):

 

 

For purposes of the foregoing formula,

 

A = the total number of shares with
respect to which this Warrant is then being exercised.

 

B = the VWAP per share of the Common
Stock (as reported by Bloomberg) on the Trading Day immediately preceding the date of the Exercise Notice.

 

C = the Exercise Price then in effect
for the applicable Warrant Shares at the time of such exercise.

 

“VWAP” means, for
any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted
on a national securities exchange, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on the exchange on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day
from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if the Common Stock is not then listed or quoted for
trading on a national securities exchange and if prices for the Common Stock are then reported by OTC Markets, Inc. (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (c) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company

 

    	-3-

    	 

    

 

(e)
Except as otherwise provided for herein, this Warrant shall not entitle the Holder to any voting rights or other rights
as a stockholder of the Company by virtue of the ownership hereof.

 

5.
Delivery of Warrant Shares.

 

(a)
Upon exercise of this Warrant, the Company shall promptly (but in no event later than three Trading Days after the Exercise
Date) issue or cause to be issued and deliver or cause to be delivered to the Holder, in such name or names as the Holder may designate,
a certificate for the Warrant Shares issuable upon such exercise (the “Certificate”), which may bear
a restrictive legend if required pursuant to Section 4.1 of the Subscription Agreement between the Company and the initial Holder
dated October 1, 2014 (the “Subscription Agreement”) . The Holder, or any Person so designated by the Holder to receive
the Warrant Shares, shall be deemed to have become holder of record of such Warrant Shares as of the Exercise Date.

 

(b)
 This Warrant and the Warrant Shares may only be transferred in accordance with Section 4.1 of the Subscription Agreement.

 

(c)
This Warrant is exercisable, either in its entirety or, from time to time, for a portion of the number of Warrant Shares.
Upon surrender of this Warrant following one or more partial exercises, the Company shall issue or cause to be issued, at its expense,
a New Warrant evidencing the right to purchase the remaining number of Warrant Shares.

 

(d)
To the extent permitted by law, the Company’s obligations to issue and deliver Warrant Shares in accordance with the
terms hereof are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver
or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same,
or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other
Person of any obligation to the Company or any violation or alleged violation of law by the Holder or any other Person, and irrespective
of any other circumstance which might otherwise limit such obligation of the Company to the Holder in connection with the issuance
of Warrant Shares. Nothing herein shall limit the Holder’s right to pursue any other remedies available to it hereunder,
in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s
failure to timely deliver Common Stock upon exercise of this Warrant as required pursuant to the terms hereof.

 

6.
Charges, Taxes and Expenses. Issuance and delivery of certificates for shares of Common Stock upon exercise of this
Warrant shall be made without charge to the Holder for any issue or transfer tax, withholding tax, transfer agent fee or other
incidental tax or expense in respect of the issuance of such certificates, all of which taxes and expenses shall be paid by the
Company; provided, however, that the Company shall not be required to pay any tax which may be payable in respect
of any transfer involved in the issue, delivery or registration of any certificates for Warrant Shares or Warrant in a name other
than that of the Holder and that the Holder will be required to pay any tax with respect to cash received in lieu of fractional
shares. The Holder shall be responsible for all other tax liability of the Holder that may arise as a result of holding or transferring
this Warrant or receiving Warrant Shares upon exercise hereof.

 

    	-4-

    	 

    

  

7.
Replacement of Warrant. If this Warrant is mutilated, lost, stolen or destroyed, the Company, at the sole expense
of the Holder (such expenses, if any imposed by the Company to be reasonable), shall issue or cause to be issued in exchange and
substitution for and upon cancellation hereof, or in lieu of and in substitution for this Warrant, a New Warrant, but only upon
receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction and customary and reasonable indemnity,
if requested by the Company.

 

8.
Reservation of Warrant Shares. The Company covenants that it will at all times reserve and keep available out of
the aggregate of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue
Warrant Shares upon exercise of this Warrant as herein provided, the number of Warrant Shares which are then issuable and deliverable
upon the exercise of this entire Warrant, free from all taxes, liens, claims, encumbrances with respect to the issuance of such
Warrant Shares and will not be subject to any pre-emptive rights or similar rights (taking into account the adjustments and restrictions
of Section 9 hereof). The Company covenants that all Warrant Shares so issuable and deliverable shall, upon issuance
and the payment of the applicable Exercise Price in accordance with the terms hereof, be duly and validly authorized, issued, fully
paid and nonassessable. The Company will take all such action as may be necessary to assure that such shares of Common Stock may
be issued as provided herein without violation of any applicable law or regulation, or of any requirements of any securities exchange
or automated quotation system upon which the Common Stock may be listed or quoted, as the case may be.

 

9.
Certain Adjustments. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant are subject
to adjustment from time to time as set forth in this Section 9.

 

(a)
Stock Dividends. If the Company, at any time while this Warrant is outstanding, pays a dividend on its Common Stock
payable in additional shares of Common Stock or otherwise makes a distribution on any class of capital stock that is payable in
shares of Common Stock, then in each such case the Exercise Price shall be multiplied by a fraction, (A) the numerator of
which shall be the number of shares of Common Stock outstanding immediately prior to the opening of business on the day after the
record date for the determination of stockholders entitled to receive such dividend or distribution and (B) the denominator
of which shall be the number of shares of Common Stock outstanding immediately after the distribution date of such dividend or
distribution. Any adjustment made pursuant to this Section 9(a) shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution; provided, however, that if
following such record date the Company rescinds or modifies such dividend or distribution, the Exercise Price shall be appropriately
adjusted (as of the date that the Company effectively rescinds or modifies such dividend or distribution) to take into account
the effect of such rescinded or modified dividend or distribution on the Exercise Price pursuant to this Section 9(a).

 

(b)
Stock Splits. If the Company, at any time while this Warrant is outstanding, (i) subdivides outstanding shares
of Common Stock into a larger number of shares, or (ii) combines outstanding shares of Common Stock into a smaller number
of shares, then in each such case the Exercise Price shall be multiplied by a fraction, (A) the numerator of which shall be
the number of shares of Common Stock outstanding immediately before such event and (B) the denominator of which shall be the
number of shares of Common Stock outstanding immediately after such event. Any adjustment pursuant to this Section 9(b)
shall become effective immediately after the effective date of such subdivision or combination.

 

(c)
Reclassifications. A reclassification of the Common Stock (other than any such reclassification in connection with
a merger or consolidation to which Section 9(e) applies) into shares of any other class of stock shall be deemed:

 

(i)a
distribution by the Company to the holders of its Common Stock of such shares of such other class of stock for the purposes and
within the meaning of this Section 9; and

 

    	-5-

    	 

    

  

(ii)if
the outstanding shares of Common Stock shall be changed into a larger or smaller number of shares of Common Stock as part of such
reclassification, such change shall be deemed a subdivision or combination, as the case may be, of the outstanding shares of Common
Stock for the purposes and within the meaning of Section 9(b).

 

(d)
Other Distributions. If the Company, at any time while this Warrant is outstanding, distributes to holders of Common
Stock (i) evidences of its indebtedness, (ii) shares of any class of capital stock, (iii) rights or warrants to
subscribe for or purchase any shares of any class of capital stock or (iv) any other asset, other than a distribution of Common
Stock covered by Section 9(a), (in each case, “Distributed Property”), then in each such case
the Exercise Price in effect immediately prior to the record date fixed for determination of stockholders entitled to receive such
distribution (and the Exercise Price thereafter applicable) shall be adjusted (effective on and after such record date) to equal
the product of such Exercise Price multiplied by a fraction, (A) the numerator of which shall be Market Price on such record
date less the then fair market value of the Distributed Property distributed in respect of one outstanding share of Common Stock,
which, if the Distributed Property is other than cash or marketable securities, shall be as reasonably determined in good faith
by the Board of Directors of the Company whose determination shall be described in a board resolution, and (B) the denominator
of which shall be the Market Price on such record date; provided, however, that if following the record date for such distribution
the Company rescinds or modifies such distribution, the Exercise Price shall be appropriately adjusted (as of the date that the
Company effectively rescinds or modifies such distribution) to take into account the effect of such rescinded or modified distribution
on the Exercise Price pursuant to this Section 9(d).

 

(e)
Fundamental Transactions. If, at any time while this Warrant is outstanding, (i) the Company effects any merger
or consolidation of the Company with or into another Person, (ii) the Company effects any sale of all or substantially all of its
assets or a majority of its stock acquired by a third party, in each case in one or a series of related transactions, (iii) any
tender offer or exchange offer by another Person is completed pursuant to which all or substantially all of the holders of Common
Stock are permitted to tender or exchange their shares for other securities, cash or property or (iv) there shall occur any
merger of another Person into the Company whereby the Common Stock is cancelled, converted or reclassified into or exchanged for
other securities, cash or property (in any such case, a “Fundamental Transaction”), then, as a condition
to the consummation of such Fundamental Transaction, the Company shall (or, in the case of any Fundamental Transaction in which
the Company is not the surviving entity, the Company shall take all reasonable steps to cause such other Person to execute and
deliver to the Holder of this Warrant a written instrument providing that:

 

(x)           so long as this
Warrant remains outstanding, upon the exercise hereof at any time on or after the consummation of such Fundamental Transaction
and on such terms and subject to such conditions as shall be nearly equivalent as may be practicable to the provisions set forth
in this Warrant, this Warrant shall be exercisable into, in lieu of Common Stock issuable upon such exercise prior to such consummation,
the securities or other property (the “Substituted Property”) that would have been received in connection with such
Fundamental Transaction by a holder of the number of shares of Common Stock into which this Warrant was exercisable immediately
prior to such Fundamental Transaction, assuming such holder of Common Stock:

 

(A)        is not a Person with which the Company consolidated or into which the Company merged or which merged
into the Company or to which such sale or transfer was made, as the case may be (a “Constituent Person”),
or an Affiliate of a Constituent Person; and

 

    	-6-

    	 

    

 

(B)        failed to exercise such Holder’s
rights of election, if any, as to the kind or amount of securities, cash and other property receivable in connection with such
Fundamental Transaction (provided, however, that if the kind or amount of securities, cash or other property receivable
in connection with such Fundamental Transaction is not the same for each share of Common Stock held immediately prior to such Fundamental
Transaction by a Person other than a Constituent Person or an Affiliate thereof and in respect of which such rights of election
shall not have been exercised (a “Non-Electing Share”), then, for the purposes of this Section 9(e),
the kind and amount of securities, cash and other property receivable in connection with such Fundamental Transaction by each Non-Electing
Share shall be deemed to be the kind and amount so receivable per share by a plurality of the Non-Electing Shares); and

 

(y)           the rights and obligations
of the Company (or, in the event of a transaction in which the Company is not the surviving Person, such other Person) and the
Holder in respect of Substituted Property shall be as nearly equivalent as may be practicable to the rights and obligations of
the Company and Holder in respect of Common Stock hereunder.

 

Such written instrument shall
provide for adjustments which, for events subsequent to the effective date of such written instrument, shall be as nearly equivalent
as may be practicable to the adjustments provided for in this Section 9. The above provisions of this Section 9(e)
shall similarly apply to successive Fundamental Transactions.

 

(f)
Adjustment of Warrant Shares. Simultaneously with any adjustment to the Exercise Price pursuant to paragraphs (a)
through (d) of this Section 9, the number of Warrant Shares that may be purchased upon exercise of this Warrant shall
be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the
increased or decreased number of Warrant Shares shall be the same as the aggregate Exercise Price payable for the Warrant Shares
immediately prior to such adjustment.

 

(g)
Calculations. All calculations under this Section 9 shall be made to the nearest cent or the nearest
1/100th of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares
owned or held by or for the account of the Company, and the disposition of any such shares shall be considered an issue or sale
of Common Stock.

 

(h)
Adjustments. Notwithstanding any provision of this Section 9, no adjustment of the Exercise Price shall
be required if such adjustment is less than $0.01; provided, however, that any adjustments which by reason of this Section 9(h)
are not required to be made shall be carried forward and taken into account for purposes of any subsequent adjustment required
to be made hereunder.

 

(i)
Notice of Adjustments. Upon the occurrence of each adjustment pursuant to this Section 9, the Company
will promptly deliver to the Holder a certificate executed by the Company’s Chief Financial Officer setting forth, in reasonable
detail, the event requiring such adjustment and the method by which such adjustment was calculated, the adjusted Exercise Price
and the adjusted number or type of Warrant Shares or other securities issuable upon exercise of this Warrant (as applicable). The
Company will retain at its office copies of all such certificates and cause the same to be available for inspection at said office
during normal business hours by the Holder or any prospective purchaser of the Warrant designated by the Holder.

 

(j)
Notice of Corporate Events.  If the Company (i) declares a dividend or any other distribution of cash, securities
or other property in respect of its Common Stock, including, without limitation, any granting of rights or warrants to subscribe
for or purchase any capital stock of the Company or any subsidiary of the Company, (ii) authorizes, approves, enters into
any agreement contemplating, or solicits stockholder approval for, any Fundamental Transaction or (iii) authorizes the voluntary
dissolution, liquidation or winding up of the affairs of the Company, then the Company shall deliver to the Holder a notice describing
the material terms and conditions of such transaction at least 15 Trading Days prior to the applicable record or effective date
on which a Person would need to hold Common Stock in order to participate in or vote with respect to such transaction (but not
prior to the public announcement thereof to the Company’s common stockholders at large), and the Company will take all steps
reasonably necessary in order to ensure that the Holder is given the practical opportunity to exercise this Warrant prior to such
time so as to participate in or vote with respect to such transaction; provided, however, that the failure to deliver
such notice or any defect therein shall not affect the validity of the corporate action required to be described in such notice.

 

    	-7-

    	 

    

 

10.
Fractional Shares. The Company shall not be required to issue or cause to be issued fractional Warrant Shares on
the exercise of this Warrant. If any fraction of a Warrant Share would, except for the provisions of this Section 10, be
issuable upon exercise of this Warrant, the Company shall make a cash payment to the Holder equal to (a) such fraction multiplied
by (b) the Market Price on the Exercise Date of one full Warrant Share.

 

11.
Listing on Securities Exchanges. The Company has agreed to list, and will use its reasonable best efforts to maintain
the listing of, the Common Stock, which shall include the Warrant Shares, on Nasdaq consistent with the terms of the Subscription
Agreement, dated as October 1, 2014, by and between the Company and Holder (the “Subscription Agreement”). In
furtherance and not in limitation of any other provision of this Warrant, if the Company at any time shall list any Common Stock
on any Eligible Market other than Nasdaq, the Company will use its reasonable best efforts, at its expense, to simultaneously list
the Warrant Shares (and use its reasonable best efforts to maintain such listing) on such Eligible Market, upon official notice
of issuance following the exercise of this Warrant; and the Company will so list, register and use its reasonable best efforts
to maintain such listing on any Eligible Market any Other Securities, if and at the time that any securities of like class or similar
type shall be listed on such Eligible Market by the Company.

 

12.
Remedies. The Company stipulates that the remedies at law of the Holder of this Warrant in the event of any default
or threatened default by the Company in the performance of or compliance with any of the terms of this Warrant are not and will
not be adequate, and that such terms may be specifically enforced by a decree for the specific performance of any agreement contained
herein or by an injunction against a violation of any of the terms hereof or otherwise.

 

13.
Notices. Any and all notices or other communications or deliveries hereunder (including without limitation any Exercise
Notice) shall be in writing and shall be mailed by certified mail, return receipt requested, or by a nationally recognized courier
service or delivered (in person, by facsimile or by email), against receipt to the party to whom such notice or other communication
is to be given. Any notice or other communication given by means permitted by this Section 13 shall be deemed given at the
time of receipt thereof. The address for such notices or communications shall be as set forth below:

 

	 	If to the Company:	Inventergy Global, Inc.
	 	 	900 E. Hamilton Avenue #180
	 	 	Campbell, CA 95008
	 	 	Email: conversions@inventergy.com
	 	 	 
	 	If to the Holder: 	As set forth on the signature page to the Subscription Agreement.

 

Or such other address as is provided to such
other party in accordance with this Section 13.

 

14.
Warrant Agent. The Company shall serve as warrant agent under this Warrant. Upon a prompt written notice to the Holder,
the Company may appoint a new warrant agent. Any Person into which any new warrant agent may be merged, any Person resulting from
any consolidation to which any new warrant agent shall be a party or any Person to which any new warrant agent transfers substantially
all of its corporate trust or shareholders services business shall be a successor warrant agent under this Warrant without any
further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant agent to be mailed (by first
class mail, postage prepaid) to the Holder at the Holder’s last address as shown on the Warrant Register.

 

    	-8-

    	 

    

 

15.
Exercise Limitations; Holder’s Restrictions. The Company shall not effect any exercise of this Warrant, and
a Holder shall not have the right to exercise any portion of this Warrant, pursuant to Section 15 or otherwise, to the extent
that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together
with the Holder’s Affiliates, and any other person or entity acting as a group together with the Holder or any of the Holder’s
Affiliates), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).  For purposes of
the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates shall include
the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made,
but shall exclude the number of shares of Common Stock which would be issuable upon (A) exercise of the remaining, nonexercised
portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (B) exercise or conversion of the unexercised
or nonconverted portion of any other securities of the Company subject to a limitation on conversion or exercise analogous to the
limitation contained herein beneficially owned by the Holder or any of its affiliates.  Except as set forth in the preceding
sentence, for purposes of this Section 15, beneficial ownership shall be calculated in accordance with Section 13(d) of
the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is
not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is
solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained
in this Section 15 applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by
the Holder together with any Affiliates) and of which portion of this Warrant is exercisable shall be in the sole discretion of
the Holder, and the submission of an Exercise Notice shall be deemed to be the Holder’s determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which portion of this
Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to
verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above
shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.
For purposes of this Section 15, in determining the number of outstanding shares of Common Stock, a Holder may rely on the
number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report, as
the case may be, (B) a more recent public announcement by the Company or (C) any other notice by the Company or the transfer agent
setting forth the number of shares of Common Stock outstanding.  Upon the written or oral request of a Holder, the Company
shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. 
In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise
of securities of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of
outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable
upon exercise of this Warrant. The Holder, upon not less than 61 days’ prior notice to the Company, may increase or decrease
the Beneficial Ownership Limitation provisions of this Section 15, provided that the Beneficial Ownership Limitation in
no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance
of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 15 shall continue
to apply. Any such increase or decrease will not be effective until the 61st day after such notice is delivered to the
Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 15 to correct this paragraph (or any portion hereof) which may be defective or inconsistent with
the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

    	-9-

    	 

    

 

16.
Miscellaneous.

 

(a)
This Warrant may be assigned by the Holder, subject to compliance with applicable securities laws. This Warrant may not
be assigned by the Company, except to a successor in the event of a Fundamental Transaction. This Warrant shall be binding on and
inure to the benefit of the parties hereto and their respective successors and assigns. Subject to the preceding sentence, nothing
in this Warrant shall be construed to give to any Person other than the Company and the Holder any legal or equitable right, remedy
or cause of action under this Warrant. This Warrant may be amended only in writing signed by the Company and the Holder and their
successors and assigns.

 

(b)
The Company will not, by amendment of its governing documents or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the
taking of all such action as may be necessary or appropriate in order to protect the rights of the Holder against impairment. Without
limiting the generality of the foregoing, the Company (i) will not increase the par value of any Warrant Shares above the amount
payable therefor upon exercise thereof, and (ii) will take all such action as may be reasonably necessary or appropriate in
order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares on the exercise of this Warrant,
free from all taxes, or liens, claims and encumbrances created by the Company and (iii) will not close its shareholder books or
records in any manner which interferes with the timely exercise of this Warrant.

 

(c)
This Warrant shall be governed by and construed and enforced in accordance with the laws of the State of New York. Each
party hereby irrevocably submits to the exclusive jurisdiction of the state and Federal courts sitting in the City of New York,
Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding that it is
not personally subject to the jurisdiction of any such court or that such suit, action or proceeding is improper. Each party hereby
irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted
by law. THE PARTIES HEREBY WAIVE ALL RIGHTS TO A TRIAL BY JURY.

 

(d)
Neither party shall be deemed in default of any provision of this Warrant, to the extent that performance of its obligations
or attempts to cure a breach hereof are delayed or prevented by any event reasonably beyond the control of such party, including,
without limitation, war, hostilities, acts of terrorism, revolution, riot, civil commotion, national emergency, strike, lockout,
unavailability of supplies, epidemic, fire, flood, earthquake, force of nature, explosion, embargo, or any other Act of God, or
any law, proclamation, regulation, ordinance, or other act or order of any court, government or governmental agency, provided
that such party gives the other party written notice thereof promptly upon discovery thereof and uses reasonable best efforts to
cure or mitigate the delay or failure to perform.

 

(e)
The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit
or affect any of the provisions hereof.

 

(f)
In case any one or more of the provisions of this Warrant shall be deemed invalid or unenforceable in any respect, the validity
and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby and
the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable
substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK,

SIGNATURE PAGE FOLLOWS]

 

    	-10-

    	 

    

  

IN WITNESS WHEREOF, the Company has caused this
Warrant to be duly executed by its authorized officer as of the date first indicated above.

 

	 	INVENTERGY GLOBAL, INC.
	 	 	 	 
	 	By:	 	 
	 	 	Name: 	Joseph W. Beyers
	 	 	Title:	Chief Executive Officer and Chairman
	 	 	 	 
	 	CF DB EZ LLC
	 	 	 	 
	 	By:	 	 
	 	 	Name: 	 
	 	 	Title: 	 

 

[Signature
Page To Warrant]

 

    	 

    	 

    

  

APPENDIX A

 

FORM OF ASSIGNMENT

 

(to be completed and signed only upon transfer
of Warrant)

 

FOR VALUE RECEIVED, the undersigned hereby sells,
assigns and transfers unto ________________________________________ the right represented by the within Warrant to purchase _____________
shares of Common Stock of Inventergy Global, Inc. to which the within warrant relates and appoints __________________________ attorney
to transfer said right on the books of Inventergy Global, Inc. with full power of substitution in the premises.

 

	Dated:____________	 
	 	(Signature must conform in all respects to name of Holder as specified on face of the Warrant)
	 	 
	 	Address of Transferee:
	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	In the presence of:	 
	 	 	 
	 	 	 	 

 

The Transferee hereby represents and warrants
to Inventergy Global, Inc. that it is an “accredited investor” within the meaning of SEC Rule 501(a), and that it is
not purchasing this Warrant (or portion thereof) pursuant to any general solicitation by the transferor nor on the basis of any
information about the Company other than materials posted on the SEC’s EDGAR website or the Company’s press releases.

 

	 	 	 	 
	 	Transferee	 

 

	 	By:	 	 
	 	Name:	 
	 	Title:	 

 

    	 

    	 

    

  

APPENDIX B

 

FORM OF EXERCISE NOTICE

 

(To be executed by the Holder to exercise the right to purchase
shares of Common Stock under the foregoing Warrant)

 

		To:	Inventergy Global, Inc.

 

The undersigned is the Holder of Warrant No. [          
] (the “Warrant”) issued by Inventergy Global, Inc., a Delaware corporation (the “Company”).
Capitalized terms used herein and not otherwise defined have the respective meanings set forth in the Warrant.

 

		1.	The Warrant is currently exercisable to purchase a total of _________ Warrant Shares.

 

		2.	The undersigned Holder hereby exercises its right to purchase _________ Warrant Shares pursuant to the Warrant.

 

		3.	The Holder intends that payment of the Exercise Price shall be made as:

 

		a.	A “Cash Exercise” with respect to _________ Warrant Shares; and/or

 

		b.	A “Cashless Exercise” with respect to __________ Warrant Shares.

 

		4.	In the event that the Holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be issued pursuant
hereto, the Holder shall pay the sum of $________ to the Company in accordance with the terms of the Warrant.

 

		5.	Pursuant to this exercise, the Company shall deliver to the Holder _________ Warrant Shares in accordance with the terms of
the Warrant

 

		6.	Following this exercise, the Warrant shall be exercisable to purchase a total of __________ Warrant Shares.

 

		7.	The Holder is an “accredited investor” within the meaning of SEC Rule 501(a).

 

	Dated: ____________	Name of Holder:
	 	 
	 	(Print)	 
	 	 
	 	By:	 
	 	 
	 	Title:	 
	 	 
	 	(Signature must conform in all respects to name of Holder as specified on face of the Warrant)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00245-of-00352.parquet"}]]